Integrative Profiling of Tumor and Blood Microenvironments to Uncover Molecular and Immune Determinants of Prognosis and Treatment Efficacy in Metastatic Colorectal Cancer
This review summarizes the most promising biomarkers currently being investigated in metastatic colorectal cancer, including those measured in tumor tissue and those detected through blood-based tests, as well as emerging metabolic and lipid-related signatures.